Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(TSX:
SVA
)
0.8300
UNCHANGED
Streaming Delayed Price
Updated: 3:34 PM EDT, May 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about SVA
< Previous
1
2
Next >
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
May 10, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
May 01, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
February 22, 2023
Via
Investor Brand Network
Sinovac Amends Shareholder Rights Plan
February 22, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines
September 13, 2022
Via
JCN Newswire
Exposures
COVID-19
SINOVAC Reports Unaudited First Half of 2022 Financial Results
December 29, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Varicella Vaccine Prequalified by WHO
November 03, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC to Showcase Products at CPHI Frankfurt
October 28, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
SVA DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
October 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SINOVAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm
October 14, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sinovac Biotech Ltd. (SVA) Investors of Class Action Deadline Against 1Globe Capital LLC and to Actively Participate
October 14, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
October 11, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Deadline in Lawsuit on October 17, 2022
October 10, 2022
San Diego, CA -- (SBWIRE) -- 10/10/2022 -- The Shareholders Foundation announced that a deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd....
Via
SBWire
SVA FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
October 10, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
SVA FINAL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
October 09, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
October 05, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
October 02, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
October 02, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A LEADING LAW FIRM, Encourages Sinovac Biotech Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
September 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Indonesia's Bio Farma ready to produce 'IndoVac' Covid-19 vaccines
September 12, 2022
Via
ACN Newswire
Exposures
COVID-19
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
September 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
September 09, 2022
Via
ACN Newswire
Exposures
COVID-19
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
September 06, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Lawsuit Alleges Securities Laws Violations by 1Globe Capital LLC
September 02, 2022
San Diego, CA -- (SBWIRE) -- 09/02/2022 -- An investor, who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ:SVA), filed a lawsuit over alleged Securities Laws violations by 1Globe Capital...
Via
SBWire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
August 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate
August 26, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
SINOVAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm
August 19, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
August 17, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
August 03, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
July 19, 2022
From
Sinovac Biotech Ltd.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.